ADIL News
Archived Headlines
- US IPO Week Ahead: 3 IPOs in last major week of 2017 12/08/17
- Alcohol dependency biotech Adial Pharmaceuticals set to price $14 million IPO during the week of December 11 11/28/17
- US IPO Weekly Recap: 6 new filings signal an active fall 09/08/17
- Alcohol-abuse biotech Adial Pharmaceuticals files and sets terms for $14 million IPO 09/07/17
Micro-cap alcoholism biotech Adial Pharmaceuticals prices IPO at $5
Adial Pharmaceuticals, which is developing a targeted therapy for alcohol use disorder based on an approved drug, raised $7.3 million by offering 1.46 million units at $5 per unit. The company had been on file to offer 1.5 million units at $5. Units consist of...read more
Alcohol abuse biotech Adial Pharmaceuticals lowers terms of $7.5 million IPO
Adial Pharmaceuticals, which is developing a targeted therapy for alcohol use disorder based on an approved drug, lowered the proposed deal size for its upcoming IPO on Monday. The Charlottesville, VA-based company now plans to raise $7.5 million by...read more
US IPO Week Ahead: 10 IPOs expected to price, led by PagSeguro's $1.8 billion deal
Ten deals are expected to price next week, raising a combined $3.1 billion in proceeds, as this month gears up to be the busiest January in over eight years in terms of proceeds raised ($3.1 billion raised to date). The week will be headlined by the "Paypal...read more
US IPO Week Ahead: 4-IPO week to close out 2017
Four companies are targeting $247 million in the last active week of the 2017 IPO market. LexinFintech, a Chinese online microloan company, leads the pack with the largest deal of the week. Other IPOs include a life insurer and two small health care deals. While...read more